Skip to main content
BMC Pulmonary Medicine logoLink to BMC Pulmonary Medicine
. 2016 Jul 23;16:105. doi: 10.1186/s12890-016-0270-9

Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands

Thys van der Molen 1, Dirkje S Postma 2, Richard J Martin 3, Ron M C Herings 4, Jetty A Overbeek 4, Victoria Thomas 5, Cristiana Miglio 5, Richard Dekhuijzen 6, Nicolas Roche 7, Theresa Guilbert 8, Elliot Israel 9, Wim van Aalderen 10, Elizabeth V Hillyer 5, Simon van Rysewyk 11, David B Price 11,12,
PMCID: PMC4958282  PMID: 27450521

Erratum

The original version of this article [1] unfortunately contained errors that have since been corrected.

The word “pharmo” has been fully capitalised to “PHARMO” throughout the article.

The reference to Table 2 in the first and second sentence under the Outcomes heading has been replaced with Fig. 3.

Under the Abbreviations heading ‘extrafine-particle’ was repeated, this has been corrected to ‘EF-HFA-BDP [Qvar®]: extrafine-particle hydrofluoroalkane beclomethasone dipropionate’.

The competing interests of Nicolas Roche and Theresa Guibert have been amended.

Academic affiliations for Dirkje S. Postma (2), Richard J. Martin (3), Ron M.C. Herrings (4), Jetty Overbeek (4), and Nicolas Roche (7) have been corrected.

Figure 3 in the online and pdf version did not match, this been amended.

Footnotes

The online version of the original article can be found under doi:10.1186/s12890-016-0234-0.

References


Articles from BMC Pulmonary Medicine are provided here courtesy of BMC

RESOURCES